title: Reovirus uses multiple endocytic pathways for cell entry.
abstract: Entry of reovirus virions has been well studied in several tissue culture systems. After attachment to junctional adhesion molecule A (JAM-A), virions undergo clathrin-mediated endocytosis followed by proteolytic disassembly of the capsid and penetration to the cytoplasm. However, during in vivo infection of the intestinal tract, and likely in the tumor microenvironment, capsid proteolysis (uncoating) is initiated extracellularly. We used multiple approaches to determine if uncoated reovirus particles, called intermediate subviral particles (ISVPs), enter cells by directly penetrating the limiting membrane or if they take advantage of endocytic pathways to establish productive infection. We found that entry and infection by reovirus ISVPs was inhibited by dynasore, an inhibitor of dynamin-dependent endocytosis, as well as by genistein and dominant-negative caveolin-1, which block caveolar endocytosis. Inhibition of caveolar endocytosis also reduced infection by reovirus virions. Extraction of membrane cholesterol with methyl-β-cyclodextrin inhibited infection by virions but had no effect when infection was initiated with ISVPs. We found this pathway to be independent of both clathrin and caveolin. Together, these data suggest that reovirus virions can use both dynamin-dependent and dynamin-independent endocytic pathways during cell entry, and they reveal that reovirus ISVPs can take advantage of caveolar endocytosis to establish productive infection.
authors.affiliation: Department of Microbiology, University of Minnesota, Minneapolis, Minnesota, USA.
authors.forename: Wade L
authors.initials: WL
authors.lastname: Schulz
authors.forename: Amelia K
authors.initials: AK
authors.lastname: Haj
authors.forename: Leslie A
authors.initials: LA
authors.lastname: Schiff
mesh_terms: D000818:Animals; D051242:Caveolin 1 / Q000494:pharmacology; D002460:Cell Line; D002470:Cell Survival / Q000502:physiology; D022163:Clathrin-Coated Vesicles / Q000821:virology*; D034281:Dynamins / Q000037:antagonists & inhibitors; D004705:Endocytosis / Q000187:drug effects; D005347:Fibroblasts / Q000821:virology*; D005434:Flow Cytometry; D019833:Genistein / Q000494:pharmacology; D006835:Hydrazones / Q000494:pharmacology*; D015151:Immunoblotting; D051379:Mice; D018613:Microscopy, Confocal; D030102:Orthoreovirus, Mammalian / Q000502:physiology*; D014771:Virion / Q000502:physiology*; D053586:Virus Internalization / Q000187:drug effects*; D047392:beta-Cyclodextrins
chemical_list: D051242:Caveolin 1; D006835:Hydrazones; C511794:N'-(3,4-dihydroxybenzylidene)-3-hydroxy-2-naphthahydrazide; D047392:beta-Cyclodextrins; C108732:methyl-beta-cyclodextrin; D019833:Genistein; D034281:Dynamins